Current advances in Hodgkin's lymphoma.
Ontology highlight
ABSTRACT: Hodgkin's lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentuximab vedotin and immune checkpoint inhibitors has revolutionized the care of Hodgkin's lymphoma. This is a review of the current advances in the management of Hodgkin's lymphoma and a review of ongoing clinical trials in the field.
SUBMITTER: Vadakara J
PROVIDER: S-EPMC6450804 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA